100 3 Patho Kreisbild 04
 

Publikationen von PD Dr. med. Jörg Nährig

 

Publikationsverzeichnis (ohne Poster und Vorträge) – Buchbeiträge (8)

  1. Schreer I., S.H.Heywang-Köbrunner, S. Barter, J. Nährig: Benign Disorders. 
In: Diagnostic Breast Imaging, Sylvia H. Heywang-Koebrunner, Ingrid Schreer, Sue Barter. 
Thieme Verlag, Stuttgart, 3rd Edition, 2013.
     
  2. Sue Barter, Sylvia Heywang-Kobrunner and Fleur Kilburn-Toppin, J. Nährig: B3 Lesions. In: Diagnostic Breast Imaging, Sylvia H. Heywang-Koebrunner, Ingrid Schreer, Sue Barter. Thieme Verlag, Stuttgart, 3rd Edition, 2013. 
     
  3. Schreer I., S.H.Heywang-Köbrunner, S. Barter, J. Nährig: Carcinoma in situ. In: Diagnostic Breast Imaging, Sylvia H. Heywang-Koebrunner, Ingrid Schreer, Sue Barter. Thieme Verlag, Stuttgart, 3rd Edition, 2013. 
     
  4. Schreer I., S.H.Heywang-Köbrunner, S. Barter, J. Nährig: Chapter 16: Invasive Carcinoma. In: Diagnostic Breast Imaging, Sylvia H. Heywang-Koebrunner, Ingrid Schreer, Sue Barter. Thieme Verlag, Stuttgart, 3rd Edition, 2013. 
     
  5. D. Mayr, K. Sotlar, B. Högel, W. Permanetter, J. Nährig. Pathologie des Mammakarzinoms. In: Mammakarzinom: Empfehlungen zur Diagnostik, Therapie und Nachsorge. Manual Tumorzentrum München an den Medizinischen Fakultäten der Ludwig-Maximilians-Universität und der Technischen Universität München (12. Auflage 2009). Zuckschwerdt Verlag, München.
     
  6. J. Nährig, B. Högel, S. Marlow, D. Mayr, W. Permanetter. Pathologie des Mammakarzinoms, in: Mammakarzinom. Empfehlungen zur Diagnostik, Therapie und Nachsorge. Manual Tumorzentrum München an den Medizinischen Fakultäten der Ludwig-Maximilians-Universität und der Technischen Universität München (11. Auflage 2007). Zuckschwerdt Verlag, München.
     
  7. Werner M, Nährig J, Lassmann, S, Höfler H. Spezielle Prognosefaktoren: Disseminierte Tumorzellen. In: Praxis der Visceralchirurgie, Hrg. Siewert, J. R., Harder, F., Rothmund, M., Band 2: Onkolgische Chirurgie, Springer Verlag, Berlin. 2001.
     
  8. Nährig J, Höfler H: Intraoperative Examination of Sentinel Lymph nodes. In: The Sentinel Lymph node concept, Alfred Schauer, Reiser Maximilian, Becker Wolfgang (Hrsg.). Springer New York, Heidelberg. 2002.
     

Originalarbeiten (64)

  1. Hrabetz H, Thiermann H, Felgenhauer N, Zilker T, Haller B, Nährig J, Saugel B, Eyer F. Organophosphate poisoning in the developed world - a single centre experience from here to the millennium. Chem Biol Interact. 2013 Dec 5;206(3):561-8.
     
  2. Spinner CD, Vogelmann R, Hoffmann D, Nährig J, Schmid RM, von Delius S. [CMV-associated enterocolitis due to primary CMV infection in the immunocompetent]. Z Gastroenterol. 2013 Nov;51(11):1259-63.
     
  3. Steigerwald K, Titova A, Malle C, Kennerknecht E, Jilek C, Hausleiter J, Nährig JM, Laugwitz KL, Joner M. Morphological assessment of renal arteries after radiofrequency catheter-based sympathetic denervation in a porcine model. J Hypertens. 2012 Nov;30(11):2230-9.
     
  4. Rieger A, Bachmann J, Schulte-Frohlinde E, Burzin M, Nährig J, Friess H, Martignoni ME. Total gastric necrosis subsequent to acute pancreatitis. Pancreas. 2012 Mar;41(2):325-7.
     
  5. Langer R, Rauser S, Feith M, Nährig JM, Feuchtinger A, Friess H, Höfler H, Walch A. Assessment of ErbB2 (Her2) in oesophageal adenocarcinomas: summary of a revised immunohistochemical evaluation system, bright field double in situ hybridisation and fluorescence in situ hybridisation. Mod Pathol. 2011 Jul;24(7):908-16.
     
  6. Heywang-Köbrunner SH, Nährig J, Hacker A, Sedlacek S, Höfler H. B3 Lesions: Radiological Assessment and Multi-Disciplinary Aspects. Breast Care (Basel). 2010 Aug;5(4):209-217. 
     
  7. Reiser-Erkan C, Erkan M, Ulbrich E, Nährig J, Kleeff J. Cystic colon duplication causing intussusception in a 25-year-old man: report of a case and review of the literature. BMC Surg. 2010 Jun 23;10:19.
     
  8. Matevossian E, Kern H, Hüser N, Doll D, Snopok Y, Nährig J, Altomonte J, Sinicina I, Friess H, Thorban S. Surgeon Yurii Voronoy (1895-1961) - a pioneer in the history of clinical transplantation: in memoriam at the 75th anniversary of the first human kidney transplantation. Transpl Int. 2009 Dec;22(12):1132-9. 
     
  9. Matevossian E, Doll D, Hüser N, Brauer R, Sinicina I, Nährig J, Friess H, Stangl M, Assfalg V. Liver transplantation in the rat: single-center experience with technique, long-term survival, and functional and histologic findings. Transplant Proc. 2009 Jul-Aug;41(6):2631-6.
     
  10. Matevossian E, Doll D, Sinicina I, Kern H, Bald C, Nährig J, Stangl M, Thorban S, Hüser N. Microsurgical technique of simultaneous pancreas/kidney transplantation in the rat: clinical experience and review of the literature. Eur Surg Res. 2009;43(2):245-51.
     
  11. Heywang-Köbrunner SH, Heinig A, Hellerhoff K, Holzhausen HJ, Nährig J. Use of ultrasound-guided percutaneous vacuum-assisted breast biopsy for selected difficult indications. Breast J. 2009 Jul-Aug;15(4):348-56.
     
  12. Nährig J. [Practical problems in breast screening. Columnar cell Lesions including flat epithelial atypia and lobular neoplasia]. Pathologe. 2008, Nov;29, Suppl 2:172-7.
     
  13. Sassen S, Schmalfeldt B, Avril N, Kuhn W, Busch R, Höfler H, Fend F, Nährig J. Histopathologic assessment of tumor regression after neoadjuvant chemotherapy in advanced-stage ovarian cancer. Hum Pathol. 2007 Jun;38(6):926-34.
     
  14. Nährig J, Höfler H, Heywang-Köbrunner SH, Prat N, Hölzel D, Wünsch PH, Lebeau A. [Experiences of the Bavarian mammography screening program]. Pathologe. 2006 Sep;27(5):387-91.
     
  15. Thussbas C, Nahrig J, Streit S, Bange J, Kriner M, Kates R, Ulm K, Kiechle M, Hoefler H, Ullrich A, Harbeck N. FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer. J Clin Oncol. 2006 Aug 10;24(23):3747-55.
     
  16. Nährig JM, Richter T, Kuhn W, Avril N, Flatau B, Kowolik J, Höfler H, Werner M. Intraoperative examination of sentinel lymph nodes by ultrarapid immunohistochemistry. Breast J. 2003 Jul-Aug;9(4):277-81.
     
  17. Nährig J, Richter T, Kowolik J, Kuhn W, Avril N, Höfler H, Werner M. Comparison of different histopathological methods for the examination of sentinel lymph nodes in breast cancer. Anticancer Res. 2000 May-Jun;20(3B):2209-12. 
     
  18. Langer R, Rauser S, Feith M, Nährig JM, Feuchtinger A, Friess H, Höfler H, Walch A. Assessment of ErbB2 (Her2) in oesophageal adenocarcinomas: summary of a revised immunohistochemical evaluation, bright field double in situ hybridisation and fluorescence in situ hybridisation. Mod Pathol. 2011 Apr 22.
     
  19. Matevossian E, Kern H, Hüser N, Doll D, Snopok Y, Nährig J, Altomonte J, Sinicina I, Friess H, Thorban S. Surgeon Yurii Voronoy (1895-1961) - a pioneer in the history of clinical transplantation: in memoriam at the 75th anniversary of the first human kidney transplantation. Transpl Int. 2009 Dec;22(12):1132-9.
     
  20. Matevossian E, Doll D, Hüser N, Brauer R, Sinicina I, Nährig J, Friess H, Stangl M, Assfalg V. Liver transplantation in the rat: single-center experience with technique, long-term survival, and functional and histologic findings. Transplant Proc. 2009 Jul-Aug;41(6):2631-6. 
     
  21. Heywang-Köbrunner SH, Heinig A, Hellerhoff K, Holzhausen HJ, Nährig J. Use of ultrasound-guided percutaneous vacuum-assisted breast biopsy for selected difficult indications. Breast J. 2009 Jul-Aug;15(4):348-56
     
  22. Sadr-Nabavi A, Ramser J, Volkmann J, Naehrig J, Wiesmann F, Betz B, Hellebrand H, Engert S, Seitz S, Kreutzfeld R, Sasaki T, Arnold N, Schmutzler R, Kiechle M, Niederacher D, Harbeck N, Dahl E, Meindl A. Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker. Int J Cancer. 2009 Apr 1;124(7):1727-35.
     
  23. Specht K, Harbeck N, Smida J, Annecke K, Reich U, Naehrig J, Langer R, Mages J, Busch R, Kruse E, Klein-Hitpass L, Schmitt M, Kiechle M, Hoefler H. Expression profiling identifies genes that predict recurrence of breast cancer after adjuvant CMF-based chemotherapy. Breast Cancer Res Treat. 2009 Nov;118(1):45-56.
     
  24. Nährig J. [Practical problems in breast screening. Columnar cell lesions including flat epithelial atypia and lobular neoplasia]. Pathologe. 2008 Nov;29, Suppl 2:172-7.
     
  25. Heywang-Köbrunner SH, Nährig J, Hacker A. [Mammography screening. Concept, quality assurance and interdisciplinary cooperation]. Pathologe. 2008 Nov;29 Suppl 2:163-7.
     
  26. Matevossian E, Sinicina I, Thorban S, Nährig J, Simon G, Hüser N, Doll D. Oesophagogastric muscular rupture after resuscitation. ANZ J Surg. 2008 Aug;78(8):719.
     
  27. Harbeck N, Nimmrich I, Hartmann A, Ross JS, Cufer T, Grützmann R, Kristiansen G, Paradiso A, Hartmann O, Margossian A, Martens J, Schwope I, Lukas A, Müller V, Milde-Langosch K, Nährig J, Foekens J, Maier S, Schmitt M, Lesche R. Multicenter study using paraffin-embedded tumor tissue testing PITX2 DNA methylation as a marker for outcome prediction in tamoxifen-treated, node-negative breast cancer patients. J Clin Oncol. 2008 Nov 1;26(31):5036-42. 
     
  28. Fauser C, Nährig J, Niedermeyer HP, Arnold W. Proliferative myositis: a rare pseudomalignant tumor of the head and neck. Arch Otolaryngol Head Neck Surg. 2008. Apr;134(4):437-40. 
     
  29. Beer AJ, Niemeyer M, Carlsen J, Sarbia M, Nährig J, Watzlowik P, Wester HJ, Harbeck N, Schwaiger M. Patterns of alphavbeta3 expression in primary and metastatic human breast cancer as shown by 18F-Galacto-RGD PET. J Nucl Med. 2008 Feb;49(2):255-9.
     
  30. Wiese AH, Auer J, Lassmann S, Nährig J, Rosenberg R, Höfler H, Rüger R, Werner M. Identification of gene signatures for invasive colorectal tumor cells. Cancer Detect Prev. 2007;31(4):282-95.
     
  31. Bernhard H, Neudorfer J, Gebhard K, Conrad H, Hermann C, Nährig J, Fend F, Weber W, Busch DH, Peschel C. Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer. Cancer Immunol Immunother. 2008 Feb;57(2):271-80.
     
  32. Maier S, Nimmrich I, Koenig T, Eppenberger-Castori S, Bohlmann I, Paradiso A, Spyratos F, Thomssen C, Mueller V, Nährig J, Schittulli F, Kates R, Lesche R, Schwope I, Kluth A, Marx A, Martens JW, Foekens JA, Schmitt M, Harbeck N; European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group. DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients--Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group. Eur J Cancer. 2007 Jul;43(11):1679-86. Epub 2007 Jun 29.
     
  33. Lindemann K, Resau J, Nährig J, Kort E, Leeser B, Annecke K, Welk A, Schäfer J, Vande Woude GF, Lengyel E, Harbeck N. Differential expression of c-Met, ist ligand HGF/SF and HER2/neu in DCIS and adjacent normal breast tissue. Histopathology. 2007 Jul;51(1):54-62.
     
  34. Bembenek AE, Rosenberg R, Wagler E, Gretschel S, Sendler A, Siewert JR, Nährig J, Witzigmann H, Hauss J, Knorr C, Dimmler A, Gröne J, Buhr HJ, Haier J, Herbst H, Tepel J, Siphos B, Kleespies A, Koenigsrainer A, Stoecklein NH, Horstmann O, Grützmann R, Imdahl A, Svoboda D, Wittekind C, Schneider W, Wernecke KD, Schlag PM. Sentinel lymph node biopsy in colon cancer: a prospective multicenter trial. Ann Surg. 2007 Jun;245(6):858-63.
     
  35. Röper B, Nüse N, Busch R, Zimmermann FB, Nährig J, Molls M. Tissue characterization of locoregionally advanced head-and-neck squamous cell carcinoma(HNSCC) using quantified ultrasonography: a prospective phase II study on prognostic relevance. Radiother Oncol. 2007 Oct;85(1):48-57.
     
  36. Piert M, Burian M, Meisetschläger G, Stein HJ, Ziegler S, Nährig J, Picchio M, Buck A, Siewert JR, Schwaiger M. Positron detection for the intraoperative localisation of cancer deposits.
     
  37. Sassen S, Schmalfeldt B, Avril N, Kuhn W, Busch R, Höfler H, Fend F, Nährig J. Histopathologic assessment of tumor regression after neoadjuvant chemotherapy in advanced-stage ovarian cancer. Hum Pathol. 2007 Jun;38(6):926-34.
     
  38. Becker KF, Schott C, Hipp S, Metzger V, Porschewski P, Beck R, Nährig J, Becker I, Höfler H. Quantitative protein analysis from formalin-fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis. J Pathol. 2007 Feb;211(3):370-8.
     
  39. Nährig J, Höfler H, Heywang-Köbrunner SH, Prat N, Hölzel D, Wünsch PH, Lebeau A. [Experiences of the Bavarian mammography screening program]. Pathologe. 2006 Sep;27(5):387-91.
     
  40. Thussbas C, Nahrig J, Streit S, Bange J, Kriner M, Kates R, Ulm K, Kiechle M, Hoefler H, Ullrich A, Harbeck N. FGFR4 Arg388 allele is associated with resistance to adjuvant therapy in primary breast cancer. J Clin Oncol. 2006 Aug 10;24(23):3747-55.
     
  41. Langer R, Von Rahden BH, Nahrig J, Von Weyhern C, Reiter R, Feith M, Stein HJ, Siewert JR, Höfler H, Sarbia M. Prognostic significance of expression patterns of c-erbB-2, p53, p16INK4A, p27KIP1, cyclin D1 and epidermal growth factor receptor in oesophageal adenocarcinoma: a tissue microarray study. J Clin Pathol. 2006 Jun;59(6):631-4.
     
  42. Lassmann S, Hennig M, Rosenberg R, Nährig J, Schreglmann J, Krause F, Poignee-Heger M, Nekarda H, Höfler H, Werner M. Thymidine phosphorylase, dihydropyrimidine dehydrogenase and thymidylate synthase mRNA expression in primary colorectal tumors-correlation to tumor histopathology and clinical follow-up. Int J Colorectal Dis. 2006 Apr;21(3):238-47.
     
  43. Hlouschek V, Domagk D, Naehrig J, Siewert JR, Domschke W. Gastric duplication cyst: a rare endosonographic finding in an adult. Scand J Gastroenterol. 2005 Sep;40(9):1129-31. 
     
  44. Stein HJ, Feith M, Bruecher BL, Naehrig J, Sarbia M, Siewert JR. Early esophageal cancer: pattern of lymphatic spread and prognostic factors for long-term survival after surgical resection. Ann Surg. 2005 Oct;242(4):566-73; discussion 573-5.
     
  45. Avril N, Sassen S, Schmalfeldt B, Naehrig J, Rutke S, Weber WA, Werner M, Graeff H, Schwaiger M, Kuhn W. Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer. J Clin Oncol. 2005 Oct 20;23(30):7445-53. Epub 2005 Sep 12. Erratum in: J Clin Oncol. 2005 Dec 20;23(36):9445.
     
  46. Kremer M, Quintanilla-Martínez L, Nährig J, von Schilling C, Fend F. Immunohistochemistry in bone marrow pathology: a useful adjunct for morphologic diagnosis. Virchows Arch. 2005 Dec;447(6):920-37. 
     
  47. Friederichs J, Gertler R, Rosenberg R, Nahrig J, Führer K, Holzmann B, Dittler HJ, Dahm M, Thorban S, Nekarda H, Siewert JR. Prognostic impact of CK-20-positive cells in peripheral venous blood of patients with gastrointestinal carcinoma. World J Surg. 2005 Apr;29(4):422-8. 
     
  48. Dahl E, Sadr-Nabavi A, Klopocki E, Betz B, Grube S, Kreutzfeld R, Himmelfarb M, An HX, Gelling S, Klaman I, Hinzmann B, Kristiansen G, Grützmann R, Kuner R, Petschke B, Rhiem K, Wiechen K, Sers C, Wiestler O, Schneider A, Höfler H, Nährig J, Dietel M, Schäfer R, Rosenthal A, Schmutzler R, Dürst M, Meindl A, Niederacher D. Systematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancer. J Pathol. 2005 Jan;205(1):21-8. 
     
  49. Gamboa-Dominguez A, Dominguez-Fonseca C, Quintanilla-Martinez L,Reyes-Gutierrez E, Green D, Angeles-Angeles A, Busch R, Hermannstädter C, Nährig J, Becker KF, Becker I, Höfler H, Fend F, Luber B. Epidermal growth factor receptor expression correlates with poor survival in gastric adenocarcinoma from Mexican patients: a multivariate analysis using a standardized immunohistochemical detection system. Mod Pathol. 2004 May;17(5):579-87. 
     
  50. Burian M, Stein HJ, Sendler A, Piert M, Nährig J, Feith M, Siewert JR. Sentinel node detection in Barrett's and cardia cancer. Ann Surg Oncol. 2004 Mar;11(3 Suppl):255S-8S. 
     
  51. Rosenberg R, Friederichs J, Gertler R, Hoos A, Mueller J, Nahrig J, Nekarda H, Siewert JR. Prognostic evaluation and review of immunohistochemically detected disseminated tumor cells in peritumoral lymph nodes of patients with pN0 colorectal cancer. Int J Colorectal Dis. 2004 Sep;19(5):430-7.
     
  52. Nährig JM, Richter T, Kuhn W, Avril N, Flatau B, Kowolik J, Höfler H, Werner M. Intraoperative examination of sentinel lymph nodes by ultrarapid immunohistochemistry. Breast J. 2003 Jul-Aug;9(4):277-81.
     
  53. Weirich G, Nährig J, Treiber U, Hartmann C, Hartung R, Höfler H, Fend F. Immunohistochemical assessment of a testicular tumor in a 63-year-old patient: proposal for an integrated clinicopathologic approach. Appl Immunohistochem Mol Morphol. 2003 Mar;11(1):96-100. 
     
  54. Aubele M, Auer G, Braselmann H, Nährig J, Zitzelsberger H, Quintanilla-Martinez L, Smida J, Walch A, Höfler H, Werner M. Chromosomal imbalances are associated with metastasis-free survival in breast cancer patients. Anal Cell Pathol. 2002;24(2-3):77-87.
     
  55. van Randenborgh H, Paul R, Nahrig J, Egelhof P, Hartung R. Extramammary Paget's disease of penis and scrotum. J Urol. 2002 Dec;168(6):2540-1. 
     
  56. Lassmann S, Bauer M, Soong R, Schreglmann J, Tabiti K, Nährig J, Rüger R, Höfler H, Werner M. Quantification of CK20 gene and protein expression in colorectal cancer by RT-PCR and immunohistochemistry reveals inter- and intratumour heterogeneity. J Pathol. 2002 Oct;198(2):198-206. 
     
  57. Cabras AD, Weirich G, Fend F, Nährig J, Bordi C, Höfler H, Werner M. Oligoclonality of a "composite" gastric diffuse large B-cell lymphoma with areas of marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type. Virchows Arch. 2002 Feb;440(2):209-14. 
     
  58. Rudolph J, Nährig J, Werner M, Mäurer J. [Cystic space-occupying lesion of the pancreas. Invasive mucinous cystadenocarcinoma of the tail of the pancreas]. Radiologe. 2001 Oct;41(10):923-6. 
     
  59. Möhrenschlager M, Vocks E, Wessner DB, Nährig J, Ring J. Tripe palms and malignant acanthosis nigricans: cutaneous signs of imminent metastasis in bladder cancer? J Urol. 2001 May;165(5):1629-30. 
     
  60. Aubele M, Cummings M, Walsch A, Zitzelsberger H, Nährig J, Höfler H, Werner M. Heterogeneous chromosomal aberrations in intraductal breast lesions adjacent to invasive carcinoma. Anal Cell Pathol. 2000;20(1):17-24. 
     
  61. Nährig J, Richter T, Kowolik J, Kuhn W, Avril N, Höfler H, Werner M. Comparison of different histopathological methods for the examination of sentinel lymph nodes in breast cancer. Anticancer Res. 2000 May-Jun;20(3B):2209-12. 
     
  62. Kowolik JH, Kuhn W, Nährig J, Werner M, Obst T, Avril N, Schmitt M, Graeff H. Detection of micrometastases in sentinel lymph nodes of the breast applying monoclonal antibodies AE1/AE3 to pancytokeratins. Oncol Rep. 2000 Jul-Aug;7(4):745-9.
     
  63. Schelling M, Avril N, Nährig J, Kuhn W, Römer W, Sattler D, Werner M, Dose J, Jänicke F, Graeff H, Schwaiger M. Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. J Clin Oncol. 2000 Apr;18(8):1689-95.
     
  64. Richter T, Nährig J, Komminoth P, Kowolik J, Werner M. Protocol for ultrarapid immunostaining of frozen sections. J Clin Pathol. 1999 Jun;52(6):461-3.